The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for Moderna’s COVID-19 vaccine, as expected after an independent panel
moderna
FDA grants emergency use authorization for Pfizer’s COVID-19 vaccine, distribution to begin within days
The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the COVID-19 vaccine developed by Pfizer and its partner
Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today
Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store
Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3
Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis
Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis
Moderna set to start final-stage trial of its coronavirus vaccine by July
Pharmaceutical company Moderna told Bloomberg on Thursday that it’s on pace to begin the final-stage clinical trial of its vaccine for the novel coronavirus
University of Oxford coronavirus vaccine trial aims to have 500 people in testing by mid-May
One of the largest COVID-19 vaccine trials currently underway will have over 500 volunteers actively testing its solution by the middle of next month.
A second potential COVID-19 vaccine, backed by Bill and Melinda Gates, is entering human testing
A new COVID-19 vaccine candidate is entering Phase 1 clinical human testing today, after the U.S. Food and Drug Administration (FDA) accepted an application
Flagship Pioneering raises $1.1 billion to spend on sustainability and health-focused biotech
Flagship Pioneering, the Boston-based biotech company incubator and holding company, said it has raised $1.1 billion for its Flagship Labs unit. Flagship, which raised
